相关实验视频

Updated: Jun 28, 2025

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

胰岛素激素,肥胖和肠道微生物群

Giulia Angelini¹, Sara Russo¹, Geltrude Mingrone²

¹Università Cattolica del Sacro Cuore, Rome, Italy.

|April 18, 2024

概括

肥胖是一个日益蔓延的流行病. 胰岛素 (依赖葡萄糖的胰岛素型多和类似葡萄糖的-1) 和肠道微生物群的代谢产物是肥胖的关键因素,影响食欲和新陈代谢.

科学领域:

代谢性疾病研究研究.
肠道微生物组研究的研究
内分泌学在内分泌学.

背景情况:

全球肥胖患病率急剧上升,构成了严重的健康挑战.
胃肠道激素,如因克雷丁 (依赖葡萄糖的胰岛素托普多和类似葡萄糖的-1),都与肥胖的发病有关.
肠道微生物群影响宿主新陈代谢,与肥胖和2型糖尿病有关.

研究的目的:

在肥胖的背景下,探索隐形素,肠道微生物群及其代谢物之间的复杂关系.
了解这些因素如何调节新陈代谢过程,包括食欲和体重.
为了确定肥胖管理的潜在治疗目标.

主要方法:

目前关于内激素和肠道微生物群的文献综述.
分析肠道微生物群代谢物 (如SCFA,醇) 在分泌中的作用.
检查减肥手术和基于隐形素的疗法对肠道微生物群的影响.

主要成果:

胰岛素会影响脂质代谢,胃排空,食欲和体重.
肠道微生物群的代谢物直接刺激肠内分泌细胞释放胰岛素,影响和食物摄入.
腹腔外科手术和隐形治疗与肠道细菌多样性的增加有关.

结论:

隐基素和肠道微生物群在调节宿主新陈代谢和能量平衡方面发挥着至关重要的作用.
准杂质素,肠道微生物群及其代谢物之间的相互作用,为肥胖症治疗提供了一个有希望的途径.
为了制定有效的管理肥胖及其伴随疾病的策略,进一步的研究是必不可少的.

关键词:

肠道代谢物的代谢物.我们的肠道微生物群.不同类型的隐形形象肥胖问题肥胖问题

更多相关视频

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

相关概念视频

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...

Hormonal Regulation

Hormonal Regulation

Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.

Anatomy of the Intestines

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...

Regulation of Food Intake

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...